![mTOR and rapamycin in the kidney: signaling and therapeutic implications beyond immunosuppression - Kidney International mTOR and rapamycin in the kidney: signaling and therapeutic implications beyond immunosuppression - Kidney International](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2043419410/2055988451/gr1.jpg)
mTOR and rapamycin in the kidney: signaling and therapeutic implications beyond immunosuppression - Kidney International
![Where and How in the mTOR Pathway Inhibitors Fight Aging: Rapamycin, Resveratrol, and Metformin | IntechOpen Where and How in the mTOR Pathway Inhibitors Fight Aging: Rapamycin, Resveratrol, and Metformin | IntechOpen](https://www.intechopen.com/media/chapter/62579/media/F1.png)
Where and How in the mTOR Pathway Inhibitors Fight Aging: Rapamycin, Resveratrol, and Metformin | IntechOpen
![Mechanism of action of different classes of mTOR inhibitors (rapalogs)... | Download Scientific Diagram Mechanism of action of different classes of mTOR inhibitors (rapalogs)... | Download Scientific Diagram](https://www.researchgate.net/profile/Joelle-Collignon/publication/262384115/figure/fig1/AS:203015328931840@1425414034127/Mechanism-of-action-of-different-classes-of-mTOR-inhibitors-rapalogs-already-approved_Q320.jpg)
Mechanism of action of different classes of mTOR inhibitors (rapalogs)... | Download Scientific Diagram
![Mechanism of action of sirolimus. Multiple downstream targets of the... | Download Scientific Diagram Mechanism of action of sirolimus. Multiple downstream targets of the... | Download Scientific Diagram](https://www.researchgate.net/profile/Joseph-Antin-2/publication/8435451/figure/fig1/AS:267425200513030@1440770544712/Mechanism-of-action-of-sirolimus-Multiple-downstream-targets-of-the.png)
Mechanism of action of sirolimus. Multiple downstream targets of the... | Download Scientific Diagram
![mTOR inhibitors and their clinical application in cervical, endometrial and ovarian cancers: A critical review - Gynecologic Oncology mTOR inhibitors and their clinical application in cervical, endometrial and ovarian cancers: A critical review - Gynecologic Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2022385713/2042201259/gr1.jpg)
mTOR inhibitors and their clinical application in cervical, endometrial and ovarian cancers: A critical review - Gynecologic Oncology
![Frontiers | Rapamycin: A Bacteria-Derived Immunosuppressant That Has Anti-atherosclerotic Effects and Its Clinical Application | Pharmacology Frontiers | Rapamycin: A Bacteria-Derived Immunosuppressant That Has Anti-atherosclerotic Effects and Its Clinical Application | Pharmacology](https://www.frontiersin.org/files/Articles/429744/fphar-09-01520-HTML/image_m/fphar-09-01520-g001.jpg)
Frontiers | Rapamycin: A Bacteria-Derived Immunosuppressant That Has Anti-atherosclerotic Effects and Its Clinical Application | Pharmacology
![New perspectives on the use of mTOR inhibitors in allogeneic haematopoietic stem cell transplantation and graft‐versus‐host disease - Lutz - 2016 - British Journal of Clinical Pharmacology - Wiley Online Library New perspectives on the use of mTOR inhibitors in allogeneic haematopoietic stem cell transplantation and graft‐versus‐host disease - Lutz - 2016 - British Journal of Clinical Pharmacology - Wiley Online Library](https://bpspubs.onlinelibrary.wiley.com/cms/asset/a8087801-fbce-443b-a2e4-2392dec68b9f/bcp13022-fig-0001-m.jpg)
New perspectives on the use of mTOR inhibitors in allogeneic haematopoietic stem cell transplantation and graft‐versus‐host disease - Lutz - 2016 - British Journal of Clinical Pharmacology - Wiley Online Library
![Where and How in the mTOR Pathway Inhibitors Fight Aging: Rapamycin, Resveratrol, and Metformin | IntechOpen Where and How in the mTOR Pathway Inhibitors Fight Aging: Rapamycin, Resveratrol, and Metformin | IntechOpen](https://www.intechopen.com/media/chapter/62579/media/F2.png)
Where and How in the mTOR Pathway Inhibitors Fight Aging: Rapamycin, Resveratrol, and Metformin | IntechOpen
![Advances in the therapeutic use of mammalian target of rapamycin (mTOR) inhibitors in dermatology - Journal of the American Academy of Dermatology Advances in the therapeutic use of mammalian target of rapamycin (mTOR) inhibitors in dermatology - Journal of the American Academy of Dermatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/09c3a59e-67d5-4127-a702-37e53908c078/gr1_lrg.jpg)
Advances in the therapeutic use of mammalian target of rapamycin (mTOR) inhibitors in dermatology - Journal of the American Academy of Dermatology
![Inhibition of the mammalian target or rapamycin (mTOR): a potential therapeutic strategy for multiple system atrophy | SpringerLink Inhibition of the mammalian target or rapamycin (mTOR): a potential therapeutic strategy for multiple system atrophy | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10286-019-00662-4/MediaObjects/10286_2019_662_Fig1_HTML.png)
Inhibition of the mammalian target or rapamycin (mTOR): a potential therapeutic strategy for multiple system atrophy | SpringerLink
![Mechanism of action of different classes of mTOR inhibitors (rapalogs)... | Download Scientific Diagram Mechanism of action of different classes of mTOR inhibitors (rapalogs)... | Download Scientific Diagram](https://www.researchgate.net/profile/Joelle-Collignon/publication/262384115/figure/fig1/AS:203015328931840@1425414034127/Mechanism-of-action-of-different-classes-of-mTOR-inhibitors-rapalogs-already-approved.png)
Mechanism of action of different classes of mTOR inhibitors (rapalogs)... | Download Scientific Diagram
![Potential mechanisms of action of sirolimus and metformin. Sirolimus... | Download Scientific Diagram Potential mechanisms of action of sirolimus and metformin. Sirolimus... | Download Scientific Diagram](https://www.researchgate.net/profile/Navin-Pinto/publication/325659793/figure/fig1/AS:960058552758272@1605907204213/Potential-mechanisms-of-action-of-sirolimus-and-metformin-Sirolimus-directly-inhibits.gif)
Potential mechanisms of action of sirolimus and metformin. Sirolimus... | Download Scientific Diagram
![mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges | Cell & Bioscience | Full Text mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges | Cell & Bioscience | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13578-020-00396-1/MediaObjects/13578_2020_396_Fig2_HTML.png)
mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges | Cell & Bioscience | Full Text
![mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges | Cell & Bioscience | Full Text mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges | Cell & Bioscience | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13578-020-00396-1/MediaObjects/13578_2020_396_Fig1_HTML.png)
mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges | Cell & Bioscience | Full Text
![Biosynthesis of rapamycin and its regulation: past achievements and recent progress | The Journal of Antibiotics Biosynthesis of rapamycin and its regulation: past achievements and recent progress | The Journal of Antibiotics](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fja.2010.71/MediaObjects/41429_2010_Article_BFja201071_Fig2_HTML.jpg)